Genomic Valley Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	107	86	179	106	66	76
Market Cap Growth	-37.86%	-52.21%	68.80%	59.59%	-12.12%	4.87%
Enterprise Value	107	85	175	106	66	76
Last Close Price	35.11	28.00	58.59	34.71	21.75	24.75
PE Ratio	353.89	282.23	50.26	698.35	10.25	-
PS Ratio	40.09	31.97	21.21	64.23	2.44	107.14
PB Ratio	2.73	2.18	4.59	2.99	1.88	2.63
P/TBV Ratio	2.73	2.18	4.59	2.99	1.88	2.63
P/FCF Ratio	-	-	1012.58	-	-	-
P/OCF Ratio	-	-	666.52	-	-	-
EV/Sales Ratio	39.99	31.95	20.71	63.98	2.44	107.03
EV/EBITDA Ratio	244.54	195.34	39.77	694.00	7.55	-
EV/EBIT Ratio	267.18	213.42	40.00	747.67	7.62	-
EV/FCF Ratio	-	-	988.92	-	-	-
Net Debt / Equity Ratio	-0.01	-0.01	-0.01	0.00	-0.01	0.00
Net Debt / EBITDA Ratio	-0.60	-0.60	-0.10	-0.40	-0.05	0.01
Net Debt / FCF Ratio	1.38	1.38	-2.56	0.30	0.05	0.00
Asset Turnover	0.06	0.06	0.19	0.04	0.66	0.01
Quick Ratio	7.31	7.31	4.93	3.21	2.53	0.08
Current Ratio	8.41	8.41	5.73	3.68	2.89	5.31
Return on Equity (ROE)	0.77%	0.77%	9.57%	0.43%	20.24%	-0.25%
Return on Assets (ROA)	0.58%	0.58%	6.29%	0.20%	13.25%	-5.00%
Return on Invested Capital (ROIC)	0.78%	0.78%	9.54%	0.40%	27.35%	-10.26%
Return on Capital Employed (ROCE)	1.00%	1.00%	11.20%	0.40%	24.70%	-12.70%
Earnings Yield	0.28%	0.35%	1.99%	0.14%	9.76%	-0.12%
FCF Yield	-	-0.22%	0.10%	-0.19%	-11.72%	-28.17%
Buyback Yield / Dilution	0.43%	0.43%	-0.24%	0.70%	1.79%	-1.91%